GSK’s strong third quarter earnings are a sign for the company’s future after it shed its consumer products arm, so too is the progress for its RSV vaccine, which could avoid thousands of unnecessary hospitalizations each year. Yet, Aston Martin’s continued struggle with its supply chains shows that not all companies are so lucky.
Here’s the key business news from London-listed companies this morning: